Cite
HARVARD Citation
Guo, C. et al. (2022). Evaluation of pharmacokinetics and safety of talazoparib in patients with advanced cancer and varying degrees of hepatic impairment. British journal of clinical pharmacology. 88 (7), pp. 3392-3403. [Online].